Substance Use Disorder Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032)| Key Companies|Companies-MediciNova,Omeros Corp, KemPharm, InterveXion Therapeutics

DelveInsight Business Research LLP

DelveInsight’s “Substance use disorder Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Substance use disorder, historical and forecasted epidemiology as well as the Substance use disorder market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Substance Use Disorder Overview

Substance use disorder (SUD) is a treatable mental disorder that affects a person’s brain and behavior, leading to their inability to control their use of substances like legal or illegal drugs, alcohol, or medications.

Substance Use Disorder Epidemiology Insights

• The prevalence rates of both alcohol and drug dependence (1.3% and 1.8% respectively) are about one-fourth the magnitude of abuse (5.2% and 7.1%, respectively). Taken together, the lifetime prevalence rates of substance use disorders are 6.5% for alcohol and 8.9% for illicit drugs

Click here to learn more about the Substance Use Disorder Market Landscape

The Report Covers the Substance Use Disorder Epidemiology Segmented by:

• Total Substance Use Disorder prevalent cases  

• Total Substance Use Disorder incident cases 

• Total Substance Use Disorder treatment cases 

• Total Eye Neoplasm diagnosed cases 

 Substance Use Disorder Market Outlook 

The Substance Use Disorder market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Substance Use Disorder market trends by analyzing the impact of current Substance Use Disorder therapies on the market, unmet needs, drivers, barriers, and demand for better technology. This segment gives a thorough detail of the Substance Use Disorder market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Substance Use Disorder market data are presented with relevant tables and graphs to give a clear view of the market at first sight. According to DelveInsight, the Substance Use Disorder market in 7MM is expected to witness a major change in the study period 2019-2032.

Key Companies Working in the Substance Use Disorder Market

• MediciNova, 

• Omeros Corp.,

•  KemPharm, 

• InterveXion Therapeutics

And many others 

Substance Use Disorder Therapies Covered and Analyzed in the Report

• Ibudilast (MN-166) 

• OMS405 • KP879 

•  IXT-m200

And many others Learn more about the Key Companies and Emerging Therapies in the Substance Use Disorder Market

 Table of Contents 

1.  Key Insights 

2.  Substance Use Disorder Introduction 

3.  Executive Summary of  Substance Use Disorder        

4.  Disease Background and Overview

5.  Epidemiology and patient population

6.  Substance Use Disorder  Emerging Therapies

7.  Substance Use Disorder  Market Outlook

8.  Market Access and Reimbursement of Therapies

9.  Market Drivers 

10.  Market Barriers 

11.  Appendix

12.  Report Methodology

13.  DelveInsight Capabilities

14.  Disclaimer

Learn about the detailed offerings of the report @ Substance Use Disorder Market Outlook

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services